Evidence map›Paper›PMID 36291795›Full record

ArticleCancers2022

MITF Is Regulated by Redox Signals Controlled by the Selenoprotein Thioredoxin Reductase 1.

Chelsey D Kline, Madeleine Anderson, John W Bassett, Gail Kent, Rachel Berryman, Matthew Honeggar, Shosuke Ito, Kazumasa Wakamatsu, Arup K Indra, Philip J Moos and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Chelsey D KlineDepartment of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
Madeleine AndersonDepartment of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
John W BassettDepartment of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
Gail KentDepartment of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
Rachel BerrymanDepartment of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
Matthew HoneggarDepartment of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
Shosuke ItoInstitute for Melanin Chemistry, Fujita Health University, Toyoake 470-1192, Japan.ORCID 0000-0001-9182-5144
Kazumasa WakamatsuInstitute for Melanin Chemistry, Fujita Health University, Toyoake 470-1192, Japan.ORCID 0000-0003-1748-9001
Arup K IndraDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USA.ORCID 0000-0001-6137-7555
Philip J MoosDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA.
Sancy A LeachmanDepartment of Dermatology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Pamela B CassidyDepartment of Dermatology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0002-4310-9554
Oregon Health & Science University · USFujita Health University · JPOregon State University · USUniversity of Utah · US

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Grace B Gill · 1997 to 2026
$60.5M
Training in the Molecular Basis of Skin/Mucosa PathobiologyT32CA106195 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI KULESZ-MARTIN, MOLLY F. · 2004 to 2018
$3.8M
Personalized melanoma chemopreventionR01CA166710 · NCI · UNIVERSITY OF UTAH · PI CASSIDY, PAMELA B., GROSSMAN, DOUGLAS · 2012 to 2016
$1.6M
NCI NIH HHS P30 CA069533NCI NIH HHS R01 CA166710NCI NIH HHS T32 CA106195
6 · The paper itself

Abstract

TR1 and other selenoproteins have paradoxical effects in melanocytes and melanomas. Increasing selenoprotein activity with supplemental selenium in a mouse model of UV-induced melanoma prevents oxidative damage to melanocytes and delays melanoma tumor formation. However, TR1 itself is positively associated with progression in human melanomas and facilitates metastasis in melanoma xenografts. Here, we report that melanocytes expressing a microRNA directed against TR1 (TR1

Indexed as

glutathioneMITFperoxiredoxinredox signalingthioredoxin reductase 1

Identifiers

PMID36291795
PMCPMC9600194
OpenAlexW4306149711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.